EU Multistakeholder Project Aims To Give eConsent The ‘Place It Deserves’

 
• By Vibha Sharma
  
Generate a summary of this article
Listen to this article
Beta

The EU Forum for Good Clinical Practice is working on boosting the use of electronic informed consent, the uptake of which in clinical trials has been poor. 

selective focus, white tablet stylus in hand businessman,Digital signature concept. contract signature agreement.
A common misunderstanding about eConsent is that it is about remote consent or electronic signatures • Source: Shutterstock

An EU initiative that aims to support the uptake of electronic informed consent (eConsent) processes in clinical trials is making good progress and is on track to deliver practical guidance in this area next year.

Key Takeaways

  • Although eConsent has several advantages over the traditional paper-based informed consent methods, its adoption so far has been quite limited.

The initiative, which is being run by the not-for-profit, multi-stakeholder organization, the EU Forum for Good Clinical Practice (EFGCP), will...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from International

Quotable: Top Experts On Policy Hot Topics

 
• By Anabel Costa-Ferreira

The Pink Sheet highlights recent comments and insights from pharma officials and executives on key issues we are covering.

WHO To Finalize Preferred & Critical Characteristics Of New Mpox Human Vaccines

 
• By Vibha Sharma

To help sponsors developing candidate mpox vaccines, the World Health Organization will soon be finalizing guidance on the preferred and minimum characteristics these products must satisfy regarding efficacy, dose regimen and other aspects to secure regulatory approval.

WHO Urges Countries To Curb Spread Of Mpox With Vaccines, Therapeutics & Other Actions

 
• By Ian Schofield

The WHO’s emergency committee has warned of a lack of understanding of the epidemiology of mpox, the limited availability of vaccines, and the complexities of donations and procurement.

ICH Explores New Platform To Facilitate Global Evaluation Of CMC Changes

 
• By Vibha Sharma

An ongoing collaborative initiative involving global regulators assessing post-approval manufacturing changes has highlighted the need to establish a standardized platform that can facilitate the submission and regulatory evaluation of such changes.

More from Geography

Quotable: Top Experts On Policy Hot Topics

 
• By Anabel Costa-Ferreira

The Pink Sheet highlights recent comments and insights from pharma officials and executives on key issues we are covering.

Canada Cuts Red Tape With Single Ethics Review For Trials

A new research ethics review system for multi-site clinical trials in Canada is expected to help improve study start-up times, avoid unnecessary duplication and boost the country’s competitiveness on a global stage.

Nancy Test Circulable Section Geography

 
• By Brian Bossetta

This is a short description